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Sir,
We thank the correspondents for their interest in our paper and
for their constructive comments.
With regard to generation of the model for prediction
of neoplasia, our model was based on all patients in the
study, not restricted to disease-free patients as suggested by
Belobrajdic et al, using raw sMMP9 concentrations rather than
age-adjusted values. Age was a significant factor in risk of
neoplasia and hence, the final risk was adjusted through the
regression model applied.
Prospective prediction of the presence of neoplasia was
attempted, as this is a more clinically relevant exercise in the
pursuit of a non-invasive screening test for colorectal neoplasia.
Improved accuracy through regression analysis was performed to
direct future studies aimed at more accurate prediction in
populations more closely approximating screening-target groups,
rather than the high-prevalence group investigated in this
preliminary study. We agree the R
2 value of 0.027 is remarkably
small and, if accurate, would have contradicted the assertion of a
relationship between sMMP9 concentration and patient age.
Unfortunately, the value reported is a misprint (as Belobrajdic
et al, correctly state), which all authors failed to identify during
proof reading and instead should have read R
2¼0.44. We
apologise for the error.
We agree that maximum availability of data to the wider
audience is desirable and did indeed exclude the suggested age
versus sMMP9 concentration through consideration of space
constraints. Again, box-plots of sMMP9 concentrations for
individual subgroups were similarly excluded from the final draft
for reasons of conciseness and brevity. We would welcome contact
from groups with similar and comparable data sets in this field for
purposes of combined analysis.
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